Y. Kawano

Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron

J. Sparks, M. Weinblatt, N. Patel, 2022, medRxiv.

Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases

J. Sparks, N. Patel, Xiaoqing Fu, 2022, Annals of the Rheumatic Diseases.

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort study

M. Weinblatt, J. Sparks, M. Weinblatt, 2022, medRxiv.

SARS-CoV-2 virologic rebound with nirmatrelvir-ritonavir therapy

M. Siedner, J. Sparks, J. Lemieux, 2023, medRxiv.

Disease activity score in 28 joints at 3 months after the initiation of biologic agent can be a predictive target for switching to the second biologic agent in patients with polyarticular juvenile idiopathic arthritis

S. Takei, H. Imanaka, Tsuyoshi Yamatou, 2016, Modern rheumatology.